Cargando…
Targeting BAM for Novel Therapeutics against Pathogenic Gram-Negative Bacteria
The growing emergence of multidrug resistance in bacterial pathogens is an immediate threat to human health worldwide. Unfortunately, there has not been a matching increase in the discovery of new antibiotics to combat this alarming trend. Novel contemporary approaches aimed at antibiotic discovery...
Autores principales: | Overly Cottom, Claire, Stephenson, Robert, Wilson, Lindsey, Noinaj, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135246/ https://www.ncbi.nlm.nih.gov/pubmed/37107041 http://dx.doi.org/10.3390/antibiotics12040679 |
Ejemplares similares
-
Identification of a Compound That Inhibits the Growth of Gram-Negative Bacteria by Blocking BamA–BamD Interaction
por: Li, Yan, et al.
Publicado: (2020) -
Plasticity within the barrel domain of BamA mediates a hybrid-barrel mechanism by BAM
por: Wu, Runrun, et al.
Publicado: (2021) -
The Exploration of Complement-Resistance Mechanisms of Pathogenic Gram-Negative Bacteria to Support the Development of Novel Therapeutics
por: Ruest, Marta K., et al.
Publicado: (2022) -
Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria
por: Thai, Van C., et al.
Publicado: (2023) -
Synergistic Effect of Lithocholic Acid with Gentamicin against Gram-Positive Bacteria but Not against Gram-Negative Bacteria
por: Lv, Hongfa, et al.
Publicado: (2022)